Jon Oliner

2.7k citations
8 papers · 2.4k · 3 hit papers · h-index 7

Impact in

    • MicroRNA in disease regulation
    • Cancer-related molecular mechanisms research
  • Oncology top 2%
    • Cancer-related Molecular Pathways

Papers in

    • Angiogenesis and VEGF in Cancer 2
    • Peroxisome Proliferator-Activated Receptors 1
    • Epigenetics and DNA Methylation 1
    • Glycosylation and Glycoproteins Research 1
    • Cancer-related Molecular Pathways 2

Jon Oliner

8 papers receiving 2.3k citations

Jon Oliner's Hit Papers

Topological control of p21WAF1/CIP1 expression in normal and neoplastic tissues. 1995 · 526 citations
5260+11+23Years since publication250500750

Peers

Jon Oliner
Comparison fields: 5 of 97
  • Cancer Research 802
  • Oncology 939
  • Molecular Biology 1.7k
  • Biotechnology 199
  • Pathology and Forensic Medicine 156
Replace Emre Sayan with:
Emre Sayan United Kingdom
Fumihiro Higashino Japan
Steven J. Kuerbitz United States
Anne Estreicher Switzerland
Irmgard Schwarte‐Waldhoff Germany
Stephen Baylin United States
Ying C. Henderson United States
Joseph Abecassis France
Peter Würl Germany
M Terada Japan
Jon Oliner relative to Emre Sayan United Kingdom Emre Sayan's profile →
Citations per field
00.5×1.5×
Emre Sayan · 1×
Citations per year

Countries citing papers authored by Jon Oliner

Since Specialization
Citations

This map shows the geographic impact of Jon Oliner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jon Oliner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jon Oliner more than expected).

Fields of papers citing papers by Jon Oliner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jon Oliner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jon Oliner. The network helps show where Jon Oliner may publish in the future.

Co-authors

The 25 scholars most cited alongside Jon Oliner, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Jon Oliner Line = papers co-authored together Jon Oliner links everyone, so they are left out of the graph.

All Works

8 of 8 papers shown
#Work
1
Scrambled exons
Hit paper breakdown →
1991780
2
Topological control of p21WAF1/CIP1 expression in normal and neoplastic tissues.
Hit paper breakdown →
1995526
3
p53 Mutation and MDM2 amplification in human soft tissue sarcomas.
Hit paper breakdown →
1993467
4 1994239
5 1998173
6 1996134
7 201434
8 20143

About Jon Oliner

Jon Oliner is a scholar working on Molecular Biology, Oncology, Surgery, Pulmonary and Respiratory Medicine and Biotechnology, having authored 8 papers that have together received 2.4k indexed citations. Recurring topics across this work include Angiogenesis and VEGF in Cancer (2 papers), Cancer Research and Treatments (2 papers), Cancer-related Molecular Pathways (2 papers), Cholesterol and Lipid Metabolism (2 papers), Peroxisome Proliferator-Activated Receptors (1 paper), Epigenetics and DNA Methylation (1 paper), Glycosylation and Glycoproteins Research (1 paper) and Renal cell carcinoma treatment (1 paper). The work is most often cited by research in Cancer Research (802 citations), Oncology (939 citations), Molecular Biology (1.7k citations), Biotechnology (199 citations) and Pathology and Forensic Medicine (156 citations). Jon Oliner has collaborated with scholars based in United States. Frequent co-authors include Bert Vogelstein, Takashi Tokino, David E. Hill, Eric R. Fearon, Kenneth W. Kinzler, J. Michael Ruppert, Janice Nigro, S E Kern, Kathleen R. Cho and Todd Waldman. Their work appears in journals such as Genes & Development, Translational Oncology, Proceedings of the National Academy of Sciences, Cancer Research and Cell.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact